1. Guang, S, O'Brien, B M, Fine, A S, Fatemi, A, Nemeth, C L. 2023. Mutations in DARS2 result in global dysregulation of mRNA metabolism and splicing. In Scientific reports, 13, 13042. doi:10.1038/s41598-023-40107-7. https://pubmed.ncbi.nlm.nih.gov/37563224/
2. Jiang, Yingfeng, You, Jianbin, Wu, Chuncai, Chen, Liangyuan, Wu, Wenbing. 2022. High expression of DARS2 indicates poor prognosis in lung adenocarcinoma. In Journal of clinical laboratory analysis, 36, e24691. doi:10.1002/jcla.24691. https://pubmed.ncbi.nlm.nih.gov/36085578/
3. Guang, Shiqi, O'Brien, Brett, Fine, Amena Smith, Fatemi, Ali, Nemeth, Christina. 2023. Mutations in DARS2 result in global dysregulation of mRNA metabolism and splicing. In Research square, , . doi:10.21203/rs.3.rs-2603446/v1. https://pubmed.ncbi.nlm.nih.gov/36909591/
4. Liu, Xu-Sheng, Zeng, Jing, Zhang, Yao-Hua, Liu, Chao, Pei, Zhi-Jun. 2023. DARS2 is a prognostic biomarker and correlated with immune infiltrates and cuproptosis in lung adenocarcinoma. In American journal of cancer research, 13, 818-834. doi:. https://pubmed.ncbi.nlm.nih.gov/37034224/
5. Xu, Rongjian, Han, Fengyi, Zhao, Yandong, de Loos, Erik R, Zhao, Min. 2024. Role of CENPL, DARS2, and PAICS in determining the prognosis of patients with lung adenocarcinoma. In Translational lung cancer research, 13, 2729-2745. doi:10.21037/tlcr-24-696. https://pubmed.ncbi.nlm.nih.gov/39507047/
6. Li, Dongqing, Su, Hang, Deng, Xiaolin, Tan, Wanlong, Li, Fei. 2025. DARS2 Promotes Bladder Cancer Progression by Enhancing PINK1-Mediated Mitophagy. In International journal of biological sciences, 21, 1530-1544. doi:10.7150/ijbs.107632. https://pubmed.ncbi.nlm.nih.gov/39990673/
智鼠故事 
